{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:45:17Z","timestamp":1784241917415,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In recent years, numerous studies have reported the development or exacerbation of sarcoidosis due to interferon therapy. However, ocular lesions rarely present as initial symptoms. Herein, we describe a rare case of interferon-\u03b1-induced sarcoidosis with uveitis as the initial symptom, and present a review of the relevant literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>This case involved a 62-year-old-Japanese woman with a history of a combination treatment of pegylated interferon-\u03b1-2a, ribavirin, and\u00a0simeprevir, after which she developed granulomatous panuveitis. She was subsequently diagnosed with sarcoidosis following histological examination of skin biopsy specimens. In addition to reporting this case, we performed a literature review of 27 cases (24 case reports) of histopathologically diagnosed interferon-\u03b1-induced sarcoidosis published between January 2009 and November 2018.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Among the reviewed cases, 23 (85.1%) cases developed skin lesions and 19 (70.1%) had lung lesions. Only three cases (11.1%) had accompanying eye lesions. Interferon-\u03b1 therapy was discontinued in 16 cases (52.9%), and the majority exhibited improvement after systemic corticosteroid treatment. There are few reported cases of interferon-\u03b1-induced sarcoidosis with uveitis as the initial symptom. However, if uveitis develops during or after interferon-\u03b1 treatment, it might represent an initial symptom of interferon-\u03b1-induced sarcoidosis, as observed in the present case.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13256-021-03181-x","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:02:14Z","timestamp":1637971334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Interferon-induced sarcoidosis with uveitis as the initial symptom: a case report and review of the\u00a0literature"],"prefix":"10.1186","volume":"15","author":[{"given":"Ai","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Mizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,27]]},"reference":[{"key":"3181_CR1","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.4049\/jimmunol.156.12.4952","volume":"156","author":"DR Moller","year":"1996","unstructured":"Moller DR, Forman JD, Liu MC, Noble PW, Greenlee BM, Vyas P, et\u00a0al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol. 1996;156:4952\u201360.","journal-title":"J Immunol"},{"key":"3181_CR2","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S0140-6736(03)12888-7","volume":"361","author":"RP Baughman","year":"2003","unstructured":"Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003;361:1111\u20138.","journal-title":"Lancet"},{"key":"3181_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1046\/j.1365-2249.2003.02128.x","volume":"132","author":"H Sibuya","year":"2003","unstructured":"Sibuya H, Nagai T, Ishii A, Yamamoto K, Hirohata S. Differential regulation of Th1 responses and CD154 expression in human CD4+ T cells by IFN-alpha. Clin Exp Immunol. 2003;132:216\u201324.","journal-title":"Clin Exp Immunol"},{"key":"3181_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/01.md.0000157577.69729.e6","volume":"84","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Mana J, Nardi N, Brito-Zeron P, Xaubet A, Sanchez-Tapias JM, et\u00a0al. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine. 2005;84:69\u201380.","journal-title":"Medicine"},{"key":"3181_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/ICB.0b013e31815f3cfd","volume":"3","author":"N Nigam","year":"2009","unstructured":"Nigam N, Hadaya J, Freeman WR. Interferon induced sarcoid uveitis with papillitis and macula edema. Retin Cases Brief Rep. 2009;3:102\u20134.","journal-title":"Retin Cases Brief Rep."},{"key":"3181_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/hepr.12021","volume":"43","author":"S Joshita","year":"2013","unstructured":"Joshita S, Shirahata K, Yazaki Y, Okaniwa S, Nakamura Y, Kimura T, et\u00a0al. Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy. Hepatol Res. 2013;43:801\u20137.","journal-title":"Hepatol Res"},{"key":"3181_CR7","first-page":"1319","volume":"107","author":"M Iwashita","year":"2010","unstructured":"Iwashita M, Maeda T, Tagami A, Watanabe N, Takada J, Asano T, et\u00a0al. A case of cardiac sarcoidosis occurring during combination therapy by IFN alpha and ribavirin for chronic hepatitis C. Nihon Shokakibyo Gakkai Zasshi. 2010;107:1319\u201327 (In Japanese, abstract in English).","journal-title":"Nihon Shokakibyo Gakkai Zasshi."},{"key":"3181_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4103\/0974-777X.96779","volume":"4","author":"B Oudghiri","year":"2012","unstructured":"Oudghiri B, Benzagmout M, Boujraf S, Belahcen F, Ibrahimi A. Multisystem sarcoidosis in a patient on interferon-a therapy for chronic hepatitis C. J Glob Infect Dis. 2012;4:128\u201331.","journal-title":"J Glob Infect Dis."},{"key":"3181_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5152\/tjg.2016.0433","volume":"28","author":"SK Kim","year":"2017","unstructured":"Kim SK, Kim SR, Imoto S, Kim CW, Hayashi Y. Sudden-onset sarcoidosis with severe dyspnea developing during pegylated interferon and ribavirin combination therapy for chronic hepatitis C. Turk J Gastroenterol. 2017;28:75\u20136.","journal-title":"Turk J Gastroenterol"},{"key":"3181_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jfma.2014.07.008","volume":"113","author":"C Chiang","year":"2014","unstructured":"Chiang C, Lai F. Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C. J Formos Med Assoc. 2014;113:981\u20132.","journal-title":"J Formos Med Assoc"},{"key":"3181_CR11","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.ad.2012.07.007","volume":"104","author":"R Novoa","year":"2013","unstructured":"Novoa R, Barnadas MA, Torras X, Curell A, Aomar A. Foreign body granulomatous reaction to silica, silicone, and hyaluronic acid in a patient with interferon-induced sarcoidosis. Actas Dermosifiliogr. 2013;104:920\u20133.","journal-title":"Actas Dermosifiliogr"},{"key":"3181_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jdcr.2016.02.003","volume":"2","author":"JMO Salvador","year":"2016","unstructured":"Salvador JMO, Martinez AMV, Ferrer DS, Miquel VA, Ferriols AP. Interferon alpha-induced sarcoidosis resolving without drug withdrawal. JAAD Case Rep. 2016;2:146\u20139.","journal-title":"JAAD Case Rep."},{"key":"3181_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.12659\/AJCR.890180","volume":"15","author":"R Trien","year":"2014","unstructured":"Trien R, Cooper CJ, Paez D, Colon E, Ajamal S, Salameh H. Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis C. Am J Case Rep. 2014;15:235\u20138.","journal-title":"Am J Case Rep."},{"key":"3181_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000346244","volume":"226","author":"G Buss","year":"2013","unstructured":"Buss G, Cattin V, Spring P, Malinverci R, Gilliet M. Two cases of interferon-alpha-induced sarcoidosis Koebnerized along venous drainage lines: new pathogenic insights and review of the literature of interferon-induced sarcoidosis. Dermatology. 2013;226:289\u201397.","journal-title":"Dermatology"},{"key":"3181_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4103\/2230-8229.98308","volume":"19","author":"WI Albaker","year":"2012","unstructured":"Albaker WI. Hypercalcemia induced by interferon therapy in chronic hepatitis C. J Fam Community Med. 2012;19:141\u20134.","journal-title":"J Fam Community Med"},{"key":"3181_CR16","first-page":"185","volume":"82","author":"BJ Flores-Robles","year":"2017","unstructured":"Flores-Robles BJ, Sanguesa-Gomez CP, Mateos CB, Roustan-Gullon LG, Kovtun I. Sarcoidosis developing after treatment with hepatitis C: an association every physician should know. Rev Gastroenterol Mex. 2017;82:185\u20136.","journal-title":"Rev Gastroenterol Mex."},{"key":"3181_CR17","first-page":"57","volume":"22","author":"DP Parente","year":"2016","unstructured":"Parente DP, Santamaria MS, Ordonez SS, Amado LM. Pulmonary sarcoidosis in the context of a telaprevir-based triple therapy for hepatitis C. Rev Port Pneumol. 2016;22:57\u20139.","journal-title":"Rev Port Pneumol"},{"key":"3181_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.01.2011.3740","author":"M Sionidou","year":"2011","unstructured":"Sionidou M, Spyratos D, Chloros D, Sichletidis L. Interferon \u03b1-induced sarcoidosis to a patient with polycythemia vera. BMJ Case Rep. 2011. https:\/\/doi.org\/10.1136\/bcr.01.2011.3740.","journal-title":"BMJ Case Rep"},{"key":"3181_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.03.2011.3929","author":"C Cardoso","year":"2011","unstructured":"Cardoso C, Freire R, Alves A, Oliveira A. Interferon-induced sarcoidosis. BMJ Case Rep. 2011. https:\/\/doi.org\/10.1136\/bcr.03.2011.3929.","journal-title":"BMJ Case Rep"},{"key":"3181_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1365-4632.2010.04728.x","volume":"50","author":"V Lopez","year":"2011","unstructured":"Lopez V, Molina I, Monteagudo C, Jorda E. Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin; a new case and review of the literature. Int J Dermatol. 2011;50:287\u201391.","journal-title":"Int J Dermatol."},{"key":"3181_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5021\/ad.2011.23.2.239","volume":"2","author":"YB Lee","year":"2011","unstructured":"Lee YB, Lee JI, Park HJ, Cho BK, Oh ST. Interferon-alpha induced sarcoidosis with cutaneous involvement along the lines of venous drainage. Ann Dermatol. 2011;2:239\u201341.","journal-title":"Ann Dermatol"},{"key":"3181_CR22","volume":"2010","author":"R Rodriguez-Lojo","year":"2010","unstructured":"Rodriguez-Lojo R, Almagro J, Barja J, Pineyro F, Perez-Varela L, Poizo JD, et\u00a0al. Subcutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment for chronic hepatitis C. Dermatol Res Pract. 2010;2010: 230417.","journal-title":"Dermatol Res Pract"},{"key":"3181_CR23","first-page":"S1","volume":"22","author":"F Fantini","year":"2019","unstructured":"Fantini F, Padalino C, Gualdi G, Monari P, Giannetti A. Cutaneous lesions as initial signs of interferon \u03b1-induced sarcoidosis: report of three new cases and review of the literature. Dermatol Therap. 2019;22:S1-7.","journal-title":"Dermatol Therap."},{"key":"3181_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000251664","volume":"3","author":"EV Marins","year":"2009","unstructured":"Marins EV, Gaburri AK, Gaburri D, Sementilli A. Cutaneous sarcoidosis: an uncommon side effect of pegylated interferon and ribavirin use for chronic hepatitis C. Case Rep Gastroenterol. 2009;3:366\u201371.","journal-title":"Case Rep Gastroenterol"},{"key":"3181_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5070\/D34WG417HB","volume":"15","author":"F Shuja","year":"2009","unstructured":"Shuja F, Kavoussi SC, Mir MR, Jogi RP, Rosen T. Interferon induced sarcoidosis with cutaneous involvement along lines of venous drainage in a former intravenous drug user. Dermatol Online J. 2009;15:4.","journal-title":"Dermatol Online J"},{"key":"3181_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1478-3231.2009.02173.x","volume":"30","author":"D Aturi","year":"2010","unstructured":"Aturi D, Iduru S, Veluru C, Mullen K. A levitating tattoo in a hepatitis C patient on treatment. Liver Int. 2010;30:583\u20134.","journal-title":"Liver Int"},{"key":"3181_CR27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1600-0560.2011.01702.x","volume":"38","author":"J North","year":"2011","unstructured":"North J, Mully T. Alpha-interferon induced sarcoidosis mimicking metastatic melanoma. J Cutan Pathol. 2011;38:585\u20139.","journal-title":"J Cutan Pathol"},{"key":"3181_CR28","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1111\/ajco.12204","volume":"12","author":"EK Jeon","year":"2016","unstructured":"Jeon EK, Hong J, Hong SH, Kang JY, Park G, Ahn MI, et\u00a0al. First reported case of interferon-alpha-induced sarcoidosis in an Asian patient with malignant melanoma. Asia Pac J Clin Oncol. 2016;12:e347\u20139.","journal-title":"Asia Pac J Clin Oncol"},{"key":"3181_CR29","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1111\/ijd.12676","volume":"54","author":"ACD Viana de Andrade","year":"2015","unstructured":"Viana de Andrade ACD, Brito EA, Harris OMO, Viana de Andrade PD, Leite MF, Pithon MM. Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: case report. Int J Dermatol. 2015;54:e140\u20135.","journal-title":"Int J Dermatol"},{"key":"3181_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/1752-1947-7-270","volume":"7","author":"MA Saharaian","year":"2013","unstructured":"Saharaian MA, Moghadasi N, Owji M, Maboudi M, Kosari F, McGee JC, et\u00a0al. Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-\u03b2-1b: a case report. J Med Case Rep. 2013;7:270.","journal-title":"J Med Case Rep"},{"key":"3181_CR31","first-page":"29","volume":"77","author":"C Carbonelli","year":"2012","unstructured":"Carbonelli C, Montepietra S, Caruso A, Cavazza A, Feo C, Menzella F, et\u00a0al. Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy. Monaldi Arch Chest Dis. 2012;77:29\u201331.","journal-title":"Monaldi Arch Chest Dis"},{"key":"3181_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/1752-1947-6-344","volume":"6","author":"N Perousi","year":"2012","unstructured":"Perousi N, Thomas EC. Interferon-\u03b2-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report. J Med Case Rep. 2012;6:344.","journal-title":"J Med Case Rep"},{"key":"3181_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.semarthrit.2012.03.008","volume":"42","author":"SD Chakravrty","year":"2012","unstructured":"Chakravrty SD, Harris ME, Schreiner AM, Crow MK. Sarcoidosis triggered by interferon-Beta treatment of multiple sclerosis: a case report and focused literature review. Semin Arthritis Rheum. 2012;42:206\u201312.","journal-title":"Semin Arthritis Rheum"},{"key":"3181_CR34","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/1346-8138.12581","volume":"41","author":"M Shiki","year":"2014","unstructured":"Shiki M, Hida T, Yamashita T. Development of sarcoidosis during \u03b2-interferon therapy for melanoma. Int J Dermatol. 2014;41:862\u20133.","journal-title":"Int J Dermatol"},{"key":"3181_CR35","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1038\/s41598-018-27554-3","volume":"8","author":"T Hattori","year":"2018","unstructured":"Hattori T, Konno S, Shijubo N, Yamaguchi T, Sugiyama Y, Honma S, et\u00a0al. Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan. Sci Rep. 2018;8:9440.","journal-title":"Sci Rep"},{"key":"3181_CR36","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.3748\/wjg.v18.i40.5816","volume":"18","author":"V Brjalin","year":"2012","unstructured":"Brjalin V, Salupere R, Tefanova V, Prikk K, Lapidus N, J\u00f5este E. Sarcoidosis and chronic hepatitis C: a case report. World J Gastroenterol. 2012;18:5816\u201320.","journal-title":"World J Gastroenterol"},{"key":"3181_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12931-021-01818-5","volume":"22","author":"S Ronsmans","year":"2021","unstructured":"Ronsmans S, Ridder JD, Vandebroek E, Kiresblick S, Nemery B, Hoet PHM, et\u00a0al. Associations between occupational and environmental exposures and organ involvement in sarcoidosis: a retrospective case-case analysis. Respir Res. 2021;22:224.","journal-title":"Respir Res"},{"key":"3181_CR38","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00417-008-1002-5","volume":"247","author":"D Doycheva","year":"2009","unstructured":"Doycheva D, Deuter C, Stuebieger N, Zierhut M. Interferon-alpha-associated presumed ocular sarcoidosis. Graefes Arch Clin Exp Ophthalmol. 2009;247:675\u201380.","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03181-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-03181-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03181-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T13:23:18Z","timestamp":1673875398000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-03181-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,27]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3181"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-03181-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,27]]},"assertion":[{"value":"24 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"568"}}